Clinical Trial

Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to demonstrate the feasibility, acceptability, and preliminary effectiveness of a focal mass drug administration program for household members of pregnant women to protect against malaria in pregnancy.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-04 -> 2028-07 2026-07-21
minor Completion pushed: 2028-04 -> 2028-07 2026-07-21
Trial Details
NCT Number NCT07021430
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions Malaria Prevention
Enrollment 300 participants
Start Date 2026-07
Primary Completion 2028-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-20